Chronic treatment with the glutamate receptor antagonist MK-801 alters periodontal disease susceptibility

Journal of Periodontal Research

Volumn 40, Issue 1, 2005, Pages 28-35

  Breivik, Torbjørn ^a,b   Gundersen, Yngvar ^b   Osmundsen, Harald ^a   Opstad, Per Kristian ^b   Fonnum, Frode ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

Author keywords

Cytokines; Glucocorticoids; Lipopolysaccharide; Periodontal disease

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CORTICOSTERONE; CYTOKINE; DIZOCILPINE; DRUG VEHICLE; GLUCOCORTICOID RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; HORMONE; N METHYL DEXTRO ASPARTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE MODEL; DISEASE PREDISPOSITION; ESCHERICHIA COLI; EXPERIMENT; GRAM NEGATIVE BACTERIUM; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM CARE; MALE; MEASUREMENT; NONHUMAN; OUTCOMES RESEARCH; PERIODONTAL DISEASE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REGULATORY MECHANISM; STIMULATION; TIME; TISSUE INJURY;

ANIMALS; CORTICOSTERONE; DISEASE SUSCEPTIBILITY; DIZOCILPINE MALEATE; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACID ANTAGONISTS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PERIODONTAL DISEASES; PITUITARY-ADRENAL SYSTEM; RATS; RATS, INBRED F344; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 13244299226     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00765.x     Document Type: Article

References (65)

1. Lindhe J. Textbook of Clinical Periodontology. Copenhagen: Munksgaard, 1995.
2. Socransky SS, Haffajee AD. The bacterial aetiology of destructive periodontal disease. J Periodontol 1992;63:322-331.
3. Sela MN. Role of Treponema denticola in periodontal disease. Crit Rev Oral Biol Med 2001;12:399-413.
4. Kamma JJ, Slots J. Herpes virus-bacterial interaction in aggressive periodontitis. J Clin Periodontol 2003;30:420-426.
5. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510.
6. Ding Y, Haapasalo M, Kerosuo E, Lounatmaa K. Kotiranta A, Sorsa T. Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola. J Clin Periodontol 1997;24:237-248.
7. Lohinai Z, Benedek P, Feher E et al. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998;123:353-360.
8. Breivik T, Thrane PS, Murison R, Gjermo P. Emotional stress effects on immunity, gingivitis and periodontitis. Eur J Oral Sci 1996;104:327-334.
9. Breivik T, Thrane PS. Psychoneuroimmune interactions in periodontal disease. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunlogy, 3rd edition. Chapter 63. San Diego, CA: Academic Press, 2001: 627-644.
10. Hugoson A, Ljungquist B, Breivik T. The relationship of some negative events and psychological factors to periodontal disease in an adult Swedish population 50-80 years of age. J Clin Periodontol 2002;29: 247-253.
11. Genco RJ, Ho AW, Kopman J, Grossi SG, Dunford RG, Tedesco LA. Models to evaluate the role of stress in periodontal disease. Ann Periodontol 1998;3:288-302.
12. Wimmer G, Janda M, Wieselmann-Penkner K, Jakse N, Polansky R, Pertl C. Coping with stress: Its influence on periodontal disease. J Periodontol 2002;73: 1343-1351.
13. Michalowicz B. Genetic and heritable risk factors in periodontal disease. J Periodontol 1994;65:479-488.
14. Burt BA. Periodontitis and ageing: reviewing recent evidence. J Am Dent Assoc 1994;125:273-279.
15. Hugoson A, Jordan T. Frequency distribution of individuals aged 20-70 years according to severity of periodontal disease. Community Dent Oral Epidemiol 1982;10:187-192.
16. Thorsteinson H, Hugoson A. Periodontal disease experience in adult long-duration insulin-dependent diabetics. J Clin Periodontol 1993;20:352-358.
17. Breivik T, Opstad PK, Gjermo P, Thrane PS. Effects of hypothalamic-pituitary-adrenal axis reactivity on periodontal tissue destruction in rats. Eur J Oral Sci 2000;108:115-122.
18. Breivik T, Sluyter F, Hof M, Cools A. Differential susceptibility to periodontitis in genetically selected Wistar rat lines that differ in their behavioral and endocrinological response to stressors. Behav Genet 2000;30:123-130.
19. Breivik T, Thrane PS, Gjermo P, Opstad PK. Glucocorticoid receptor antagonist RU-486 treatment reduces periodontitis in Fischer 344 rats. J Periodont Res 2000;35: 285-290.
20. Breivik T, Thrane PS, Gjermo P, Opstad PK, Pabst R, von Horsten S. Hypothalamic-pituitary-adrenal axis activation by experimental periodontal disease in rats. J Periodont Res 2001;36:295-300.
21. Breivik T, Thrane PS, Gjermo P, Fonnum F. Postnatal glutamate-induced central nervous system lesions alter periodontal disease susceptibility in adult Wistar rats. J Clin Periodontol 2001;28:904-909.
22. Breivik T, Thrane Gjermo P, Cools A, Myhrer T. Effects of hippocampal lesioning on experimental periodontal disease in Wistar rats. J Periodont Res 2002;37:360-365.
23. Breivik T, Stephan M, Brabant GE, Straub RH, Pabst R, von Horsten S. Postnatal lipopolysaccharide-induced illness predisposes to periodontal disease in adulthood. Brain Behav Immun 2002;16: 421-438.
24. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332: 1351-1361.
25. Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 1999;10:359-368.
26. Beaulieu S, Pelletier G, Vaudry H, Barden N. Influence of the central nucleus of the amygdala on the content of corticotropin-relasing factor in the median eminence. Neuroendocrinology 1989;49:255-261.
27. Lightman SL, Windle RJ, Ma XM et al. Hypothalamic-pituitary-adrenal function. Arch Physiol Biochem 2002;110:90-93.
28. Borovikova LV, Ivanokova S, Zhang M, Yang H, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-462.
29. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999;79:1-71.
30. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Brain corticosteroid receptor balance in health and disease. Endocrinol Rev 1998;19:269-301.
31. Ziegler DR, Herman JP. Local integration of glutamate signalling in the hypothalamic para ventricular region: regulation of glucocorticoid stress responses. Endocrinology 2000;141:4801-4804.
32. Abraham I, Juhasz G, Kekesi KA, Kovacs KJ. Corticosterone peak is responsible for the stress-induced elevation of glutamate in the hippocampus. Stress 1997;2:71-181.
33. Espey MG, Basil AS. Glutamate augments retrovirus-induced immunodeficiency through chronic stimulation of the hypothalamic-pituitary- adrenal axis. J Immunol 1999;162:4998-5002.
34. Lee S, Rivier C, Torres G. Induction of c-fos and CRF mRNA by MK-801 in the parvocellular paraventricular nucleus of the rat hypothalamus. Mol Brain Res 1994;24:192-1998.
35. Pechnick RN, George R, Poland RE. Characterisation of the effects of acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat. Eur J Pharmacol 1989;164:257-263.
36. Hesselink MB, Smolders H, De Boer AG, Breimer DD, Danysz W. Modifications of the behavioural profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+) MK-801 after chronic administration. Behav Pharmacol 1999;10:85-98.
37. Harkin A, Morris K, Kelly JP, O'Donnell JM, Leonard BE. Modulation of MK-801-induced behaviour by noradrenergic agents in mice. Psychopharmacology 2001;154:177-188.
38. Sluyter F, Breivik T, Cools A. Manipulation in the maternal environment reverse genetically predisposed periodontitis in rats. Clin Diagn Lab Immunol 2002;4:931-932.
39. Kavelaars A, Heijnen CJ, Ellenbroek B, van Loveren H, Cools A. Apomorphine-susceptible and apomorphine-unsusceptible Wistar rats differ in their susceptibility to inflammatory and infectious diseases: a study on rats with group-specific differences in structure and reactivity of hypothalamic-pituitary-adrenal axis. J Neurosci 1997;17:2580-2584.
40. Howards AD, Zwilling BS. Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin Exp Immunol 1999;115:428-434.
41. Van den Pol AN, Trombley PQ. Glutamate neurons in hypothalamus regulate excitatory transmission. J Neurosci 1993; 13:2829-2836.
42. Feldman S, Weidenfeld J. Hypothalamic mechanisms mediating glutamate effects on the hypothalamo-pituitary-adrenocortical axis. J Neural Transm 1997;104:633-642.
43. Vieira PL, Kalinski P, Wierenga EA, Kapsenberg ML, de Jong EC. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 1998; 161:5245-5251.
44. Visser J, van Boxel-Dezaire A, Methorst D, Brunt T, de Kloet ER, Nagelkerken L. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 1998;91:4255-4264.
45. Eguchi K, Kawakami A, Nakashima M et al. Interferon-alpha and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells. Clin Exp Immunol 1992;88:448-454.
46. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995;154:4719-4725.
47. Schmith M, Pauels H-G, Lugering N, Lugering A, Domschke W, Kucharzik T. Glucocorticoids induce apoptosis in human monocytes. Potential role of IL-1β. J Immunol 1999;163:3484-3490.
48. Rook GA. Glucocorticoids and immune function. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13:567-581.
49. Chapple CG, Srivastava M, Hunter N. Failure of macrophage activation in destructive periodontal disease. J Pathol 1998;186:281-286.
50. Tokoro Y, Matsuki Y, Yamamoto T, Suzuki T, Hara K. Relevance of local Th2-type cytokine mRNA expression in immunocompetent infiltrates in inflamed gingival tissue to periodontal diseases. Clin Exp Immunol 1997;107:166-174.
51. Breivik T, Rook GA. Prevaccination with SRL172 (heat-killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. Clin Exp Immunol 2000;120:463-467.
52. Breivik T, Rook GA. Treatment with SRL172 (heat-killed Mycobacterium vaccae) inhibits progression of established experimental periodontal disease in Wistar rats. J Periodont Res 2002;37:210-214.
53. Breivik T, Rook GA. Oral treatment with SR299 (killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. J Clin Periodontol 2003;30:931-936.
54. Daynes RA, Meikle AW, Araneo TA. Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res Immunol 1991;142:40-45.
55. Skerry TM, Taylor AF. Glutamate signalling in bone. Curr Pharm Des 2001;7:737-750.
56. Gary C, Marie H, Arora M et al. Glutamate does not play a major role in controlling bone growth. J Bone Miner Res 2001;16:742-749.
57. Martinez-Canut P, Lorca A, Magan R. Smoking and periodontal disease severity. J Clin Periodontol 1996;22:743-749.
58. Montairo da Silva AM, Oakly DA, Newman HN, Nohl FS, Lloyd HM. Psychosocial factors and adult onset rapidly progressive periodontitis. J Clin Periodontol 1996;23:789-794.
59. Moss ME, Beck JD, Kaplan BH et al. Exploratory case-control analysis of psychosocial factors and adult periodontitis. J Periodontol 1996;67:1060-1069.
60. Charlton BG, Ferrier IN. Hypothalamo-pituitary-adrenal axis abnormalities in depression: a review and a model. Psychol Med 1989;19:331-336.
61. Matta SG, Foster CA, Sharp BM. Nicotine stimulates the expression of cFos protein in the parvocellular para ventricular nucleus and brainstem catecholaminergic regions. Endocrinology 1993;132: 2149-2156.
62. Schwartz MW, Strack AM, Dallman MF. Evidence that elevated plasma corticosterone levels are caused of reduced hypothalamic corticotropin-releasing hormone gene expression in diabetes. Regul Pept 1997;72:105-112.
63. Friedman M, Green MF, Sharland DE. Assessment of hypothalamic-pituitary- adrenal function in the geriatric age group. J Geroniol 1969;24:292-297.
64. Ader R, Cohen N, Felten D. Psychoneuroimmunology: Interactions between the nervous system and the immune system. Lancet 1995;345:99-103.
65. Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today 1994;15:504-511.